Related Experiment Video
Updated: Jan 16, 2026
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
HSPB6 based on integrative multi-omics analysis can suppress colorectal cancer progression by downregulating HSPA6
Yukun Cao1, Yue Yu1, Tian Tian1
1Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, China.
Aims:
Colorectal cancer (CRC) remains one of the most common malignancies worldwide characterized by poor prognosis, and its mechanism is unclear. Small heat shock protein 6 (HSPB6) plays an important role in cardiovascular diseases. However, the role of HSPB6 in CRC remain poorly understood.
Materials And Methods:
We performed whole-genome methylation, RNA sequencing and proteomics analysis, combined with external database, to identify and validate the role of HSPB6 in CRC. We detected HSPB6 in CRC through in vitro and in vivo experiments. The downstream regulatory mechanism of HSPB6 was explored using RNA sequencing and immunoprecipitation mass spectrometry. The drug sensitivity assay conducted to evaluate the effect of HSPB6 expression on chemosensitivity.
Key Findings:
HSPB6 was hypermethylated and downregulated in CRC tissues, and its expression level was correlated with poor patient prognosis. Both the methylation and expression of HSPB6 showed high diagnostic value. Overexpression of HSPB6 inhibited proliferation, migration and invasion of CRC cells and suppress tumor growth in mice. HSPB6 directly interacted with Heat shock protein family A member 6 (HSPA6), leading to inhibition of the JNK-JUND axis. Additionally, HSPB6 overexpression increased sensitivity to oxaliplatin.
Significance:
HSPB6 may serve as a valuable diagnostic and prognostic biomarker, and as a putative tumor suppressor in CRC by downregulating HSPA6 and inhibiting the JNK-JUND signaling axis. Our findings suggest a novel therapeutic strategy for CRC patients exhibiting high HSPB6 expression, particularly in the context of oxaliplatin treatment.
More Related Videos
Related Concept Videos
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:23Abnormal Proliferation
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...